The combination of trifluridine/tipiracil conferred superior overall survival compared with placebo in the third- and fourth-line metastatic gastric cancer treatment settings. This finding, derived from an exploratory subgroup analysis of the TAGS study, was presented at the 2021 Gastrointestinal Cancers Symposium.
A total of 337 patients in the TAGS study’s (ClinicalTrials.gov identifier: NCT02500043) intention-to-treat group had received trifluridine/tipiracil as third- (n=126) or fourth-line (n=211) treatment and were compared with 64 and 106 placebo controls, respectively. Baseline characteristics were well balanced between treatment arms.
The median overall survival (OS) was significantly longer in the active treatment groups compared with the placebo groups. Median OS was 6.8 months for trifluridine/tipiracil vs 3.2 months for placebo (HR, =0.67; 95% CI, 0.47-0.97; P <.05) in the third-line group. It was 5.2 months vs 3.7 months (HR, 0.72; 95% CI, 0.55-0.95; P <.03) in the fourth-line group. The median progression-free survival also was significantly longer in the active treatment groups vs placebo groups (P= .0004 and P <.0001, respectively, for the third- and fourth-line).
Quality-of-life (QOL) results among patients in the subgroup analysis were consistent with those of the overall TAGS study population. No clinically significant deterioration in QoL, as measured by the QLQ-C30 and other subscales, was observed. The frequency of adverse events was similar between the 2 groups as well.
more recommended stories
-
ChatGPT Excels in Medical Summaries, Lacks Field-Specific Relevance
In a recent study published in.
-
Study finds automated decision minimizes high-risk medicine combinations in ICU patients
A multicenter study coordinated by Amsterdam.
-
Study Discovers Connection Between Omicron Infection and Brain Structure Changes in Men
A recent study in the JAMA.
-
Advancing COPD Prognosis: Deep Learning Models
Researchers conducted a meta-analysis in a.
-
4 in 1 Test for Swine Flu, COVID-19, RSV, and Influenza
In the United Kingdom, the first.
-
Innovative Zika Virus Defense: Needle-Free Vaccine Patch
To protect individuals from the potentially.
-
Social Media Impact on Mental Health Treatment
According to research, social media might.
-
Unveiling the Impact of Whole Grain Consumption on Slowing Memory Decline in Black Populations
Consuming a diet rich in whole.
-
$1 Cancer Treatment: Engineered Bacteria Breakthrough
What if a single one-dollar dose.
-
Pfizer COVID Booster: Half-Dose, Reduced Side Effects
In a recent report in The.
Leave a Comment